Multimodal imaging in deferoxamine retinopathy

Retina

Volumn 34, Issue 7, 2014, Pages 1428-1438

  Viola, Francesco ^a   Barteselli, Giulio ^a   Dell'Arti, Laura ^a   Vezzola, Diego ^a   Mapelli, Chiara ^a   Villani, Edoardo ^a   Ratiglia, Roberto ^a  

^a UNIVERSITY OF MILAN   (Italy)

Author keywords

confocal laser scanning ophthalmoscope; deferoxamine retinopathy; multimodal imaging; spectral domain optical coherence tomography; thalassemia

Indexed keywords

DEFEROXAMINE; SIDEROPHORE;

ADULT; ATROPHY; AUTOFLUORESCENCE IMAGING; BETA THALASSEMIA; BRUCH MEMBRANE; CLINICAL ARTICLE; CLINICAL EXAMINATION; CONFOCAL SCANNING LASER OPHTHALMOSCOPY; DISEASE COURSE; EYE INJURY; EYE PHOTOGRAPHY; FEMALE; FOLLOW UP; HUMAN; MACULAR LESION; MALE; MIDDLE AGED; MULTIMODAL IMAGING; NEAR INFRARED REFLECTANCE SPECTROSCOPY; OPHTHALMOSCOPY; OPTICAL COHERENCE TOMOGRAPHY DEVICE; PIGMENT EPITHELIUM; RETINA; RETINA DYSTROPHY; RETINA MACULA LUTEA; RETINOPATHY; RETROSPECTIVE STUDY; REVIEW; SCANNING LASER OPHTHALMOSCOPY; SPECTRAL DOMAIN OPTICAL COHERENCE TOMOGRAPHY; TREATMENT DURATION; BETA-THALASSEMIA; CHEMICALLY INDUCED; DRUG EFFECTS; FLUORESCENCE ANGIOGRAPHY; OPTICAL COHERENCE TOMOGRAPHY; PATHOLOGY; RETINAL DISEASES; YOUNG ADULT;

ADULT; BETA-THALASSEMIA; DEFEROXAMINE; FEMALE; FLUORESCEIN ANGIOGRAPHY; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; MULTIMODAL IMAGING; OPHTHALMOSCOPY; RETINA; RETINAL DISEASES; RETROSPECTIVE STUDIES; SIDEROPHORES; TOMOGRAPHY, OPTICAL COHERENCE; YOUNG ADULT;

EID: 84903274258     PISSN: 0275004X     EISSN: 15392864     Source Type: Journal    
DOI: 10.1097/IAE.0000000000000073     Document Type: Review

References (31)

1. Davies SC, Marcus RE, Hungerford JL, et al. Ocular toxicity of high-dose intravenous desferrioxamine. Lancet 1983;2: 181-184.
2. Haimovici R, D'Amico JD, Gragoudas ES, Sokol S; Deferoxamine Retinopathy Study Group. The expanded clinical spectrum of deferoxamine retinopathy. Ophthalmology 2002;109: 164-171.
3. Marciani MG, Ciaciulli P, Stefani N, et al. Toxic effects of high-dose deferoxamine treatment in patients with iron overload: an electrophysiological study of cerebral and visual function. Haematologica 1991;76: 131-134.
4. Baath JS, Lam WC, Kirby M, Chun A. Deferoxamine-related ocular toxicity: incidence and outcome in a pediatric population. Retina 2008;28: 894-899.
5. Viola F, Barteselli G, Dell'Arti L, et al. Abnormal fundus autofluorescence results of patients in long-term treatment with deferoxamine. Ophthalmology 2012;119: 1693-1700.
6. Bansal V, Elgarbly I, Ghanchi FD, Atkinson PL. Bull's eye maculopathy with deferoxamine. Eur J Haematol 2003;70: 420-421.
7. Gonzales CR, Lin AP, Engstrom RF, Kreiger AE. Bilateral vitelliform maculopathy and deferoxamine toxicity. Retina 2004;24: 464-467.
8. Genead MA, Fishman GA, Anastasakis A, Lindeman M. Macular vitelliform lesion in desferrioxamine-related retinopathy. Doc Ophthalmol 2010;121: 161-166.
9. Reddy S, Iturralde D, Meyerle C, et al. Fundus autofluorescence in retinopathy caused by deferoxamine toxicity. Retin Cases Brief Rep 2007;1: 120-122.
10. Rahi AHS, Hungerford JL, Ahmed AI. Ocular toxicity of desferrioxamine: light microscopic histochemical and ultrastructural findings. Br J Ophthalmol 1986;70: 373-381.
11. Good PA, Claxson A, Morris CJ, Blake DR. A model for desferrioxamine- induced retinopathy using the albino rat. Ophthalmologica 1990;201: 32-36.
12. Gehlbach PL, Purple RL, Hallaway PE, Hedlund BE. Polymer conjugation reduces deferoxamine induced retinopathy in an albino rat model. Invest Ophthalmol Vis Sci 1993;34: 2871-2887.
13. Helb HM, Charbel Issa P, Fleckenstein M, et al. Clinical evaluation of simultaneous confocal scanning laser ophthalmoscopy imaging combined with high-resolution, spectraldomain optical coherence tomography. Acta Ophthalmol 2010;88: 842-849.
14. Barteselli G, Bartsch DU, Viola F, et al. Accuracy of the Heidelberg Spectralis in the alignment between near-infrared image and tomographic scan in a model eye: a multicenter study. Am J Ophthalmol 2013;156: 588-592.
15. Gass JDM. Stereoscopic Atlas of Macula Diseases: Diagnosis and Treatment. St Louis, Mo: Mosby-Year Book Inc; 1997: 314-325.
16. Elsner AE, Burns SA, Weiter JJ, Delori FC. Infrared imaging of sub-retinal structures in the human ocular fundus. Vision Res 1996;36: 191-205.
17. Viola F, Villani E, Natacci F, et al. Choroidal abnormalities detected by near-infrared reflectance imaging as a new diagnostic criterion for neurofibromatosis 1. Ophthalmology 2012; 119: 369-375.
18. Spaide RF. Autofluorescence from the outer retina and subretinal space. Retina 2008;28: 5-35.
19. Zhang K, Garibaldi DC, Li Y, et al. Butterfly-shaped pattern dystrophy: a genetic, clinical, and histopathological report. Arch Ophthalmol 2002;120: 485-490.
20. Zweifel SA, Imamura Y, Freund KB, Spaide RF. Multimodal fundus imaging of pseudoxanthoma elasticum. Retina 2011;31: 482-491.
21. Sparrow JR, Yoon KD, Wu Y, Yamamoto K. Interpretations of fundus autofluorescence from studies of the bisretinoids of the retina. Invest Ophthalmol Vis Sci 2010;51: 4351-4357.
22. Burian HM, Burns CA. Ocular changes in myotonic dystrophy. Am J Ophthalmol 1967;63: 22-34.
23. Betten MG, Bilchick RC, Smith ME. Pigmentary retinopathy of myotonic dystrophy. Am J Ophthalmol 1971;72: 720-723.
24. Farmer SG, Longstreth WT Jr, Kalina RE, Todorov AB. Fleck retina in Kjellin's syndrome. Am J Ophthalmol 1985; 99: 45-50.
25. Leonardy NJ, Harbin RL, Sternberg P Jr. Pattern dystrophy of the retinal pigment epithelium in a patient with McArdle's disease. Am J Ophthalmol 1988;106: 741-742.
26. Agarwal A, Patel P, Adkins T, Gass JD. Spectrum of pattern dystrophy in pseudoxanthoma elasticum. Arch Ophthalmol 2005;123: 923-928.
27. Finger RP, Charbel-Issa P, Ladewig M, et al. Fundus autofluorescence in pseudoxanthoma elasticum. Retina 2009;29: 1496-1505.
28. McDonald HR, Schatz H, Aaberg TM. Reticular-like pigmentary patterns in pseudoxanthoma elasticum. Ophthalmology 1988;95: 306-311.
29. Zweifel SA, Spaide RF, Yannuzzi LA. Acquired vitelliform detachment in patients with subretinal drusenoid deposits (reticular pseudodrusen). Retina 2011;31: 229-234.
30. Uygun V, Kurtoglu E. Iron-chelating therapy with oral chelators in patients with thalassemia major. Hematology 2013;18: 50-55.
31. Charbel Issa P, Finger RP, Holz FG, Scholl HP. Multimodal imaging including spectral domain OCT and confocal near infrared reflectance for characterization of outer retinal pathology in pseudoxanthoma elasticum. Invest Ophthalmol Vis Sci 2009;50: 5913-5918.